Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

被引：1
|
作者：
Alvarez, Ricardo H. [1 ]
Hortobagyi, Gabriel N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 124卷 / 03期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; INDUCTION CHEMOTHERAPY; PREDICTIVE MARKERS; DOXORUBICIN; SURVIVAL; WOMEN; CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10549-010-1212-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：701 / 705
页数：5
相关论文
共 50 条
  • [21] Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
    Gianni, Luca
    Baselga, Jose
    Eiermann, Wolfgang
    Porta, Vincente Guillem
    Semiglazov, Vladimir
    Lluch, Ana
    Zambetti, Milvia
    Sabadell, Dolores
    Raab, Guenther
    Cussac, Antonio Llombart
    Bozhok, Alla
    Martinez-Agullo, Angel
    Greco, Marco
    Byakhov, Mikhail
    Lopez, Juan Jose Lopez
    Mansutti, Mauro
    Valagussa, Pinuccia
    Bonadonna, Gianni
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2474 - 2481
  • [22] Accuracy of multi-parametric breast MR imaging for predicting pathological complete response of operable breast cancer prior to neoadjuvant systemic therapy
    Tsukada, Hiroko
    Tsukada, Jitsuro
    Schrading, Simone
    Strobel, Kevin
    Okamoto, Takahiro
    Kuhl, Christiane K.
    MAGNETIC RESONANCE IMAGING, 2019, 62 : 242 - 248
  • [23] Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
    A M Al Murri
    C Wilson
    A Lannigan
    J C Doughty
    W J Angerson
    C S McArdle
    D C McMillan
    British Journal of Cancer, 2007, 96 : 891 - 895
  • [24] Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
    Robidoux, Andre
    Tang, Gong
    Rastogi, Priya
    Geyer, Charles E., Jr.
    Azar, Catherine A.
    Atkins, James N.
    Fehrenbacher, Louis
    Bear, Harry D.
    Baez-Diaz, Louis
    Sarwar, Shakir
    Margolese, Richard G.
    Farrar, William B.
    Brufsky, Adam M.
    Shibata, Henry R.
    Bandos, Hanna
    Paik, Soonmyung
    Costantino, Joseph P.
    Swain, Sandra M.
    Mamounas, Eleftherios P.
    Wolmark, Norman
    LANCET ONCOLOGY, 2013, 14 (12) : 1183 - 1192
  • [25] New Concepts for Targeted Systemic Therapy in Breast Cancer
    Liedtke, C.
    Wolf, M. K.
    Kiesel, L.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (08) : 625 - 633
  • [26] Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer Translational Breast Cancer Research Consortium Trial 017
    De los Santos, Jennifer F.
    Cantor, Alan
    Amos, Keith D.
    Forero, Andres
    Golshan, Mehra
    Horton, Janet K.
    Hudis, Clifford A.
    Hylton, Nola M.
    McGuire, Kandace
    Meric-Bernstam, Funda
    Meszoely, Ingrid M.
    Nanda, Rita
    Hwang, E. Shelley
    CANCER, 2013, 119 (10) : 1776 - 1783
  • [27] Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
    Al Murri, A. M.
    Wilson, C.
    Lannigan, A.
    Doughty, J. C.
    Angerson, W. J.
    McArdle, C. S.
    McMillan, D. C.
    BRITISH JOURNAL OF CANCER, 2007, 96 (06) : 891 - 895
  • [28] Neoadjuvant Versus Adjuvant Systemic Therapy for Operable Breast Cancer Equivalent Outcomes?
    Smith, Barbara L.
    ANNALS OF SURGERY, 2013, 257 (02) : 180 - 181
  • [29] Pathologic Response to Short Intensified Taxane-free Neoadjuvant Chemotherapy in Patients with Highly Proliferative Operable Breast Cancer
    Le Tourneau, Christophe
    Dettwiler, Sarah
    Beuzeboc, Philippe
    Alran, Severine
    Laurence, Valerie
    Pierga, Jean-Yves
    Freneaux, Paul
    Sigal-Zafrani, Brigitte
    Dieras, Veronique
    Vincent-Salomon, Anne
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 242 - 246
  • [30] Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy
    Elmore, Leisha C.
    Kuerer, Henry M.
    Barcenas, Carlos H.
    Smith, Benjamin D.
    Miggins, Makesha, V
    Lucci, Anthony
    Caudle, Abigail S.
    Meric-Bernstam, Funda
    Hunt, Kelly K.
    Teshome, Mediget
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (10) : 5477 - 5485
12345